Gene · 22
Papers2,216
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,216
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities. | Semin Liver Dis | 2021 | 34289507 | PubTator, text mining | PubMed |
| Acute Hepatitis Induced by Intravesical BCG Therapy: A Rare but Serious Complication. | Case Reports Hepatol | 2021 | 34258085 | PubTator, text mining | PubMed |
| SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy. | Clin Chim Acta | 2021 | 34245688 | PubTator, text mining | PubMed |
| Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients. | Infect Dis Now | 2021 | 34242842 | PubTator, text mining | PubMed |
| The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study. | Diabetes Ther | 2021 | 34241812 | PubTator, text mining | PubMed |
| Ferroptosis in Different Pathological Contexts Seen through the Eyes of Mitochondria. | Oxid Med Cell Longev | 2021 | 34211625 | PubTator, text mining | PubMed |
| Sialoglyco-Conjugate Abnormalities, IL-6 Trans-Signaling and Anti-Ganglioside Immune Response-Potential Interferences in Lupus Nephritis Pathogenesis. | Diagnostics (Basel) | 2021 | 34205600 | PubTator, text mining | PubMed |
| Direct Comparison of Clinical Characteristics, Outcomes, and Risk Prediction in Patients with COVID-19 and Controls-A Prospective Cohort Study. | J Clin Med | 2021 | 34204453 | PubTator, text mining | PubMed |
| Molecular Details of the Frataxin-Scaffold Interaction during Mitochondrial Fe-S Cluster Assembly. | Int J Mol Sci | 2021 | 34199378 | PubTator, text mining | PubMed |
| Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies. | Alcohol Alcohol | 2021 | 34196359 | PubTator, text mining | PubMed |
| Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome. | Horm Metab Res | 2021 | 34192792 | PubTator, text mining | PubMed |
| Working relationship between primary and specialist care in analysing elevated liver values-a survey from the point of view of gastroenterologists. | Wien Med Wochenschr | 2021 | 34185218 | PubTator, text mining | PubMed |
| Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms. | Leukemia | 2021 | 34172893 | PubTator, text mining | PubMed |
| MAN1B1-CDG: Three new individuals and associated biochemical profiles. | Mol Genet Metab Rep | 2021 | 34141584 | PubTator, text mining | PubMed |
| Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. | Case Rep Hematol | 2021 | 34136291 | PubTator, text mining | PubMed |
| [Metabolic hepatic steatosis associated with obesity in adults living in Burkina Faso]. | Pan Afr Med J | 2021 | 34122693 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis in Activated PI3K Delta Syndrome: an Illustrative Case Report. | J Clin Immunol | 2021 | 34115277 | PubTator, text mining | PubMed |
| The epigenetic regulator LSH maintains fork protection and genomic stability via MacroH2A deposition and RAD51 filament formation. | Nat Commun | 2021 | 34112784 | PubTator, text mining | PubMed |
| Potential natural immunization against atherosclerosis in hibernating bears. | Sci Rep | 2021 | 34108551 | PubTator, text mining | PubMed |
| Identifying and characterizing high-risk clusters in a heterogeneous ICU population with deep embedded clustering. | Sci Rep | 2021 | 34103544 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22/papers?page=36